Coalition Letter Calls for the Use of Lower-Cost Biosimilars

Today, ACI signed a coalition letter calling on the U.S. Congress to encourage the use of lower-priced biosimilar medicines, which would save lives and reduce healthcare costs. The letter was sent to the U.S. House of Representatives and U.S. Senate leadership, and it is available here online.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin